Pub Date : 2025-12-12eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1636667
Mathilde Letouzey, Samuel Diop, Claude Elvire Pédié Kengoum, Anne Rousseau, Noémie Hot, Juliette François, Thibaud Quibel, Paul Berveiller, Pascal Boileau, François Jouen, Imen Trabelsi, Jean Bergounioux
Objectives: The Apgar score remains subjective in key components despite its clinical importance. An objective method using infrared thermography could enhance neonatal assessment precision. To describe early surface thermal adaptation patterns during the first 10 min after birth using infrared thermography (IRT) and to benchmark these descriptive patterns against concurrently assigned Apgar scores. This feasibility study evaluates operational characteristics of IRT as a non-contact, objective adjunct to routine assessment; it does not establish prediction or clinical utility.
Study design: Prospective cohort of 223 full-term cesarean-delivered newborns at a tertiary maternity hospital (2021-2023). Whole-body IRT was captured at 1, 3, 5, and 10 min after birth (T1-T10). Infants were described by Apgar at 1 min (≤7 vs. ≥8).
Results: Descriptive visualizations showed observable differences in early surface temperature distributions for infants with lower Apgar scores at 1 min, with progressive warming and convergence between groups over time. Early rectal (central) temperatures in the low-Apgar group were sparsely recorded due to clinical priorities and are presented for transparency only.
Conclusions: IRT can visualize thermal adaptation during immediate neonatal transition and may serve as a non-contact, objective adjunct to clinical assessment. Further outcome-based validation in larger, more heterogeneous cohorts is needed before clinical implementation.Clinical Trial Registration: ClinicalTrials.gov, identifier NCT04483869.
{"title":"Newborn clinical condition assessment using infrared thermography: correlation with the Apgar score in a prospective cohort study.","authors":"Mathilde Letouzey, Samuel Diop, Claude Elvire Pédié Kengoum, Anne Rousseau, Noémie Hot, Juliette François, Thibaud Quibel, Paul Berveiller, Pascal Boileau, François Jouen, Imen Trabelsi, Jean Bergounioux","doi":"10.3389/fped.2025.1636667","DOIUrl":"10.3389/fped.2025.1636667","url":null,"abstract":"<p><strong>Objectives: </strong>The Apgar score remains subjective in key components despite its clinical importance. An objective method using infrared thermography could enhance neonatal assessment precision. To describe early surface thermal adaptation patterns during the first 10 min after birth using infrared thermography (IRT) and to benchmark these descriptive patterns against concurrently assigned Apgar scores. This feasibility study evaluates operational characteristics of IRT as a non-contact, objective adjunct to routine assessment; it does not establish prediction or clinical utility.</p><p><strong>Study design: </strong>Prospective cohort of 223 full-term cesarean-delivered newborns at a tertiary maternity hospital (2021-2023). Whole-body IRT was captured at 1, 3, 5, and 10 min after birth (T1-T10). Infants were described by Apgar at 1 min (≤7 vs. ≥8).</p><p><strong>Results: </strong>Descriptive visualizations showed observable differences in early surface temperature distributions for infants with lower Apgar scores at 1 min, with progressive warming and convergence between groups over time. Early rectal (central) temperatures in the low-Apgar group were sparsely recorded due to clinical priorities and are presented for transparency only.</p><p><strong>Conclusions: </strong>IRT can visualize thermal adaptation during immediate neonatal transition and may serve as a non-contact, objective adjunct to clinical assessment. Further outcome-based validation in larger, more heterogeneous cohorts is needed before clinical implementation.<b>Clinical Trial Registration:</b> ClinicalTrials.gov, identifier NCT04483869.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1636667"},"PeriodicalIF":2.0,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741121/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145849604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-12eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1691727
Korbinian Beil, Matthias Hermann, Nikolaus Haas, Robert Dalla-Pozza, Sebastian Michel, Andre Jakob, Marcus Fischer, Joseph Pattathu
Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is an established rescue therapy for severe pediatric acute respiratory distress syndrome (ARDS), but prolonged support is rarely reported. We describe the case of a previously healthy 6-year-old boy who developed Stevens-Johnson syndrome (SJS), complicated by progressive respiratory failure and severe ARDS. Despite maximal ventilation, oxygenation remained insufficient, and VV-ECMO was initiated on day 11 of illness. Cannulation was performed via jugular and femoral access, followed by lung-protective ventilation, repeated surfactant administration, corticosteroid therapy according to the Meduri protocol, and angiotensin-converting enzyme inhibitor therapy. ECMO support was complicated by pulmonary fibrosis, cholestatic liver dysfunction with secondary hemochromatosis, and prolonged sedation-associated delirium with subsequent critical illness polyneuropathy. The first attempt to discontinue ECMO after 90 days failed due to presumed pulmonary embolism, requiring recannulation. Ultimately, successful weaning was achieved after 113 days of VV-ECMO. The patient was transferred to a specialized pulmonary and neurological rehabilitation center and discharged home after 6 months, still dependent on a tracheostomy cannula. At the 18-month follow-up, he required only nocturnal mechanical ventilation through the tracheostomy, was attending school, and led an otherwise normal life. A trial removal of the cannula with closure of the stoma is scheduled for spring 2026. This case illustrates that prolonged VV-ECMO can allow lung recovery in pediatric patients with ARDS secondary to SJS, despite complications. Careful multidisciplinary management and preserved neurological function were key factors supporting long-term survival.
{"title":"Case Report: Successful weaning after 113 days of VV-ECMO in a pediatric patient with severe ARDS following Stevens-Johnson syndrome.","authors":"Korbinian Beil, Matthias Hermann, Nikolaus Haas, Robert Dalla-Pozza, Sebastian Michel, Andre Jakob, Marcus Fischer, Joseph Pattathu","doi":"10.3389/fped.2025.1691727","DOIUrl":"10.3389/fped.2025.1691727","url":null,"abstract":"<p><p>Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is an established rescue therapy for severe pediatric acute respiratory distress syndrome (ARDS), but prolonged support is rarely reported. We describe the case of a previously healthy 6-year-old boy who developed Stevens-Johnson syndrome (SJS), complicated by progressive respiratory failure and severe ARDS. Despite maximal ventilation, oxygenation remained insufficient, and VV-ECMO was initiated on day 11 of illness. Cannulation was performed via jugular and femoral access, followed by lung-protective ventilation, repeated surfactant administration, corticosteroid therapy according to the Meduri protocol, and angiotensin-converting enzyme inhibitor therapy. ECMO support was complicated by pulmonary fibrosis, cholestatic liver dysfunction with secondary hemochromatosis, and prolonged sedation-associated delirium with subsequent critical illness polyneuropathy. The first attempt to discontinue ECMO after 90 days failed due to presumed pulmonary embolism, requiring recannulation. Ultimately, successful weaning was achieved after 113 days of VV-ECMO. The patient was transferred to a specialized pulmonary and neurological rehabilitation center and discharged home after 6 months, still dependent on a tracheostomy cannula. At the 18-month follow-up, he required only nocturnal mechanical ventilation through the tracheostomy, was attending school, and led an otherwise normal life. A trial removal of the cannula with closure of the stoma is scheduled for spring 2026. This case illustrates that prolonged VV-ECMO can allow lung recovery in pediatric patients with ARDS secondary to SJS, despite complications. Careful multidisciplinary management and preserved neurological function were key factors supporting long-term survival.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1691727"},"PeriodicalIF":2.0,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145849279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-12eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1717513
Ingrid Hedström, Ulrika Löfkvist
Objectives: This pilot study aimed to investigate receptive and expressive grammatical abilities and functional hearing in everyday listening conditions among 4-6-year-old children with prelingual unilateral hearing loss (UHL), compared with peers with normal hearing (NH). A further aim was to explore whether grammatical abilities were associated with functional hearing and background factors such as severity and side of hearing loss, or parental education.
Methods: Eight children with UHL were recruited from hearing care clinics, and sixteen children with NH were recruited via social media. Data included questionnaires on hearing, development, and environment, and parent-reported functional hearing using PEACH+. Grammatical abilities were assessed with TROG-2 and the Swedish Gramba test. Group differences were analyzed with Mann-Whitney U-tests, and correlations were evaluated with Spearman's rank correlation.
Results: Children with UHL scored lower than NH peers on language tests, though the differences were not statistically significant. They scored significantly lower on three of four parent-reported measures of functional hearing, particularly in noisy environments. Grammatical ability did not correlate with functional hearing. Across the cohort, higher parental education was associated with better grammatical outcomes. Within the UHL group, right-sided hearing loss was associated with poorer expressive grammar, and greater severity of hearing loss was associated with increased difficulty hearing in noise.
Conclusions: Children with UHL demonstrated poorer functional hearing and tended to have slightly reduced grammatical abilities compared to peers with NH. Although the small sample size limits generalizability, these findings, together with previous research, suggest potential impacts of UHL on language development. The side and severity of hearing loss may influence outcomes, highlighting the need for further research and international consensus on assessment and management.
{"title":"Grammatical ability and functional hearing in various listening conditions in 4-6-year-old children with prelingual unilateral hearing loss: a pilot study.","authors":"Ingrid Hedström, Ulrika Löfkvist","doi":"10.3389/fped.2025.1717513","DOIUrl":"10.3389/fped.2025.1717513","url":null,"abstract":"<p><strong>Objectives: </strong>This pilot study aimed to investigate receptive and expressive grammatical abilities and functional hearing in everyday listening conditions among 4-6-year-old children with prelingual unilateral hearing loss (UHL), compared with peers with normal hearing (NH). A further aim was to explore whether grammatical abilities were associated with functional hearing and background factors such as severity and side of hearing loss, or parental education.</p><p><strong>Methods: </strong>Eight children with UHL were recruited from hearing care clinics, and sixteen children with NH were recruited via social media. Data included questionnaires on hearing, development, and environment, and parent-reported functional hearing using PEACH+. Grammatical abilities were assessed with TROG-2 and the Swedish Gramba test. Group differences were analyzed with Mann-Whitney <i>U</i>-tests, and correlations were evaluated with Spearman's rank correlation.</p><p><strong>Results: </strong>Children with UHL scored lower than NH peers on language tests, though the differences were not statistically significant. They scored significantly lower on three of four parent-reported measures of functional hearing, particularly in noisy environments. Grammatical ability did not correlate with functional hearing. Across the cohort, higher parental education was associated with better grammatical outcomes. Within the UHL group, right-sided hearing loss was associated with poorer expressive grammar, and greater severity of hearing loss was associated with increased difficulty hearing in noise.</p><p><strong>Conclusions: </strong>Children with UHL demonstrated poorer functional hearing and tended to have slightly reduced grammatical abilities compared to peers with NH. Although the small sample size limits generalizability, these findings, together with previous research, suggest potential impacts of UHL on language development. The side and severity of hearing loss may influence outcomes, highlighting the need for further research and international consensus on assessment and management.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1717513"},"PeriodicalIF":2.0,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741133/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145849457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition influencyed by genetic and environmental factors. There is emerging evidence of an association between hereditary thrombophilia and ASD, potentially mediated by impaired placental perfusion and resultant neuroinflammatory processes. This study aimed to investigate the frequency of thrombophilia-related genetic polymorphisms in children diagnosed with ASD and their mothers.
Methods: A total of 24 children with ASD aged 2-6 and their mothers were compared with 24 age-matched healthy children and their mothers. Sociodemographic, developmental and genetic data were collected. A psychiatric evaluation was performed according to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), and the children were assessed using the Autism Behavior Checklist (ABC), the Modified Checklist for Autism in Toddlers (M-CHAT) and the Ankara Developmental Screening Inventory (ADSI). Thrombophilia-related polymorphisms, including FVL G1691A, FII G20210A, C677T MTHFR and 1298AC MTHFR, FXIII-Val34Leu and PAI-1 4G/5G, were analyzed using PCR-based methods. Statistical comparisons and logistic regression analyses were performed to evaluate associations with ASD.
Results: The FXIII-Val34Leu heterozygous variant was significantly more prevalent in children with ASD (37.5% vs. 8.3%, p = 0.036) and their mothers (54.2% vs. 16.7%, p = 0.015) than in the control group. Logistic regression analysis revealed that the presence of the FXIII-Val34Leu heterozygous polymorphism in either the mother or child was associated with an approximately 4.130-fold increase in the odds of ASD (adjusted odds ratio = 4.130, 95% confidence interval = 1.180-5.300, p = 0.027). Other thrombophilia polymorphisms did not differ significantly between groups. Additionally, children with ASD exhibited significant delays in speech development and lower developmental scores across several domains.
Conclusion: This study is among the first to examine the FXIII Val34Leu mutation in children with ASD and their mothers. Further large-scale, longitudinal studies are needed to investigate thrombophilia markers in relation to ASD.
目的:自闭症谱系障碍(ASD)是一种受遗传和环境因素影响的复杂神经发育疾病。有新的证据表明遗传性血栓病和ASD之间存在关联,可能是由胎盘灌注受损和由此产生的神经炎症过程介导的。本研究旨在调查诊断为ASD的儿童及其母亲中与血栓相关的遗传多态性的频率。方法:将24例2 ~ 6岁ASD患儿及其母亲与24例同龄健康患儿及其母亲进行比较。收集了社会人口学、发育和遗传数据。根据第五版《精神障碍诊断与统计手册》(DSM-5)进行精神病学评估,使用自闭症行为检查表(ABC)、幼儿自闭症修正检查表(M-CHAT)和安卡拉发育筛查量表(ADSI)对儿童进行评估。采用基于pcr的方法分析了FVL G1691A、FII G20210A、C677T MTHFR和1298AC MTHFR、FXIII-Val34Leu和PAI-1 4G/5G等血栓相关多态性。通过统计比较和逻辑回归分析来评估与ASD的关系。结果:FXIII-Val34Leu杂合变异在ASD患儿(37.5% vs. 8.3%, p = 0.036)及其母亲(54.2% vs. 16.7%, p = 0.015)中的流行率明显高于对照组。Logistic回归分析显示,母亲或孩子中存在FXIII-Val34Leu杂合多态性与ASD的几率增加约4.130倍相关(校正优势比= 4.130,95%置信区间= 1.180-5.300,p = 0.027)。其他血栓形成多态性在两组间无显著差异。此外,患有ASD的儿童在语言发展方面表现出明显的延迟,在几个领域的发展得分较低。结论:本研究是首次在ASD儿童及其母亲中检测FXIII Val34Leu突变的研究之一。需要进一步大规模的纵向研究来调查与ASD相关的血栓形成标志物。
{"title":"Hereditary thrombophilia parameters in children with autism spectrum disorder and their mothers.","authors":"Perihan Cam Ray, Merve Doğan, Sevcan Bozdoğan, Gonca Gül, Hülya Binokay","doi":"10.3389/fped.2025.1680354","DOIUrl":"10.3389/fped.2025.1680354","url":null,"abstract":"<p><strong>Objective: </strong>Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition influencyed by genetic and environmental factors. There is emerging evidence of an association between hereditary thrombophilia and ASD, potentially mediated by impaired placental perfusion and resultant neuroinflammatory processes. This study aimed to investigate the frequency of thrombophilia-related genetic polymorphisms in children diagnosed with ASD and their mothers.</p><p><strong>Methods: </strong>A total of 24 children with ASD aged 2-6 and their mothers were compared with 24 age-matched healthy children and their mothers. Sociodemographic, developmental and genetic data were collected. A psychiatric evaluation was performed according to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), and the children were assessed using the Autism Behavior Checklist (ABC), the Modified Checklist for Autism in Toddlers (M-CHAT) and the Ankara Developmental Screening Inventory (ADSI). Thrombophilia-related polymorphisms, including FVL G1691A, FII G20210A, C677T MTHFR and 1298AC MTHFR, FXIII-Val34Leu and PAI-1 4G/5G, were analyzed using PCR-based methods. Statistical comparisons and logistic regression analyses were performed to evaluate associations with ASD.</p><p><strong>Results: </strong>The FXIII-Val34Leu heterozygous variant was significantly more prevalent in children with ASD (37.5% vs. 8.3%, <i>p</i> = 0.036) and their mothers (54.2% vs. 16.7%, <i>p</i> = 0.015) than in the control group. Logistic regression analysis revealed that the presence of the FXIII-Val34Leu heterozygous polymorphism in either the mother or child was associated with an approximately 4.130-fold increase in the odds of ASD (adjusted odds ratio = 4.130, 95% confidence interval = 1.180-5.300, <i>p</i> = 0.027). Other thrombophilia polymorphisms did not differ significantly between groups. Additionally, children with ASD exhibited significant delays in speech development and lower developmental scores across several domains.</p><p><strong>Conclusion: </strong>This study is among the first to examine the FXIII Val34Leu mutation in children with ASD and their mothers. Further large-scale, longitudinal studies are needed to investigate thrombophilia markers in relation to ASD.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1680354"},"PeriodicalIF":2.0,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12738871/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145849608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Background: </strong>Childhood allergic asthma is a widespread chronic respiratory condition that is becoming more common worldwide. Presently, the evaluation of its severity depends on clinical symptoms and inflammatory indicators like neutrophils and CRP, which are not very specific. Increasing research indicates that the gut microbiota and its metabolites-such as Bifidobacterium, Lactobacillus, short-chain fatty acids, and lipopolysaccharides-are important in immune system regulation and might affect asthma severity through the gut-lung connection. This study aims to determine if these microbial and metabolic factors can be used as new biomarkers to assess the severity of allergic in children.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on the medical records of 148 pediatric patients diagnosed with allergic asthma who were admitted to our hospital between May 2023 and September 2024. The patients were categorized into mild-to-moderate and severe-to-critical groups according to established severity grading criteria during the acute exacerbation phase. Metabolite indices of intestinal microbiota were compared between the two groups, and correlation scatter plots were generated to examine the association between these metabolites and disease severity. Subsequently, a receiver operating characteristic (ROC) curve was constructed to evaluate the predictive value of intestinal microbiota metabolites for assessing the severity of allergic asthma in children.</p><p><strong>Results: </strong>No significant differences in neutrophil/leukocyte counts, CRP, or Klebsiella prevalence were observed between the mild-moderate and severe-critical pediatric allergic asthma groups (<i>P</i> > 0.05). However, the mild-moderate group showed significantly higher levels of Bifidobacteria, Lactobacillus, acetic acid, propionic acid, and butyric acid, but lower Escherichia coli and lipopolysaccharide (LPS) than the severe-critical group (<i>P</i> < 0.05). Disease severity negatively correlated with Bifidobacteria, Lactobacillus, and these three short-chain fatty acids, and positively with E. coli and LPS (<i>P</i> < 0.05). For predicting severity, the area under the curve (AUC) was 0.686 for Bifidobacteria, 0.785 for Lactobacillus, 0.811 for E. coli, 0.711 for acetic acid, 0.653 for propionic acid, 0.788 for butyric acid, and 0.671 for LPS. Notably, a combined model integrating these markers achieved an AUC of 0.956, significantly outperforming any single predictor (<i>P</i> < 0.05). These results indicate that gut microbiota-derived metabolites hold substantial potential as biomarkers for assessing disease severity in children with allergic asthma.</p><p><strong>Conclusion: </strong>The composition of intestinal microbiota and their metabolites exhibits abnormal expression patterns in children diagnosed with allergic asthma, correlating with the severity of the disease. These alterations may serve as significant biomarkers for pr
背景:儿童过敏性哮喘是一种广泛存在的慢性呼吸系统疾病,在世界范围内变得越来越常见。目前对其严重程度的评价主要依靠临床症状和中性粒细胞、CRP等炎症指标,特异性不强。越来越多的研究表明,肠道菌群及其代谢物——如双歧杆菌、乳酸杆菌、短链脂肪酸和脂多糖——在免疫系统调节中起重要作用,并可能通过肠-肺连接影响哮喘的严重程度。本研究旨在确定这些微生物和代谢因素是否可以作为评估儿童过敏严重程度的新生物标志物。方法:回顾性分析2023年5月至2024年9月我院收治的148例儿科变应性哮喘患者的病历资料。在急性加重期,根据已建立的严重程度分级标准,将患者分为轻至中度和严重至危重组。比较两组肠道菌群代谢物指标,并绘制相关散点图,检验代谢物与疾病严重程度之间的相关性。随后,构建受试者工作特征(ROC)曲线,评价肠道菌群代谢物对评估儿童过敏性哮喘严重程度的预测价值。结果:轻中度和重度儿童过敏性哮喘组中性粒细胞/白细胞计数、CRP、克雷伯氏菌患病率差异无统计学意义(P < 0.05)。然而,轻度-中度组的双歧杆菌、乳酸菌、乙酸、丙酸和丁酸水平明显高于重度危重组,而大肠杆菌和脂多糖(LPS)水平明显低于重度危重组(P P P P)。结论:变应性哮喘患儿肠道菌群组成及其代谢产物表现出异常表达模式,与病情严重程度相关。这些改变可以作为预测儿童过敏性哮喘患者临床严重程度的重要生物标志物。
{"title":"Analysis of intestinal microorganisms and metabolite in childhood allergic asthma: role in assessing the severity of condition in children.","authors":"Zhoubin Xu, Haichao Ma, Yujuan Liu, Shiming Liang, Zhongnan Liao","doi":"10.3389/fped.2025.1680620","DOIUrl":"10.3389/fped.2025.1680620","url":null,"abstract":"<p><strong>Background: </strong>Childhood allergic asthma is a widespread chronic respiratory condition that is becoming more common worldwide. Presently, the evaluation of its severity depends on clinical symptoms and inflammatory indicators like neutrophils and CRP, which are not very specific. Increasing research indicates that the gut microbiota and its metabolites-such as Bifidobacterium, Lactobacillus, short-chain fatty acids, and lipopolysaccharides-are important in immune system regulation and might affect asthma severity through the gut-lung connection. This study aims to determine if these microbial and metabolic factors can be used as new biomarkers to assess the severity of allergic in children.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on the medical records of 148 pediatric patients diagnosed with allergic asthma who were admitted to our hospital between May 2023 and September 2024. The patients were categorized into mild-to-moderate and severe-to-critical groups according to established severity grading criteria during the acute exacerbation phase. Metabolite indices of intestinal microbiota were compared between the two groups, and correlation scatter plots were generated to examine the association between these metabolites and disease severity. Subsequently, a receiver operating characteristic (ROC) curve was constructed to evaluate the predictive value of intestinal microbiota metabolites for assessing the severity of allergic asthma in children.</p><p><strong>Results: </strong>No significant differences in neutrophil/leukocyte counts, CRP, or Klebsiella prevalence were observed between the mild-moderate and severe-critical pediatric allergic asthma groups (<i>P</i> > 0.05). However, the mild-moderate group showed significantly higher levels of Bifidobacteria, Lactobacillus, acetic acid, propionic acid, and butyric acid, but lower Escherichia coli and lipopolysaccharide (LPS) than the severe-critical group (<i>P</i> < 0.05). Disease severity negatively correlated with Bifidobacteria, Lactobacillus, and these three short-chain fatty acids, and positively with E. coli and LPS (<i>P</i> < 0.05). For predicting severity, the area under the curve (AUC) was 0.686 for Bifidobacteria, 0.785 for Lactobacillus, 0.811 for E. coli, 0.711 for acetic acid, 0.653 for propionic acid, 0.788 for butyric acid, and 0.671 for LPS. Notably, a combined model integrating these markers achieved an AUC of 0.956, significantly outperforming any single predictor (<i>P</i> < 0.05). These results indicate that gut microbiota-derived metabolites hold substantial potential as biomarkers for assessing disease severity in children with allergic asthma.</p><p><strong>Conclusion: </strong>The composition of intestinal microbiota and their metabolites exhibits abnormal expression patterns in children diagnosed with allergic asthma, correlating with the severity of the disease. These alterations may serve as significant biomarkers for pr","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1680620"},"PeriodicalIF":2.0,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12739653/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145849311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-11eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1686794
Brianna C Leigh, Lavonne M Liedl, Amy L Amsbaugh, William A Carey
Introduction: Spectral analysis of gastric aspirates obtained shortly after birth predicts the diagnosis of respiratory distress syndrome in neonates born <32 completed weeks gestation. We sought to determine whether this prototype point-of-care device measuring surfactant components in gastric aspirates could predict prolonged respiratory support needs in neonates ≥30 completed weeks gestation.
Methods: Gastric aspirates obtained within 30 min of birth were analyzed by spectroscopy to quantify surfactant components. These spectral data were entered into an existing algorithm to assess subjects' biochemical lung maturity. This algorithmic output was paired with clinical data to evaluate the performance of the algorithm in predicting subjects' need for respiratory support at six hours of life (prolonged respiratory support). Each element of the algorithm was adjusted via a machine learning framework to optimize predictive performance.
Results: Gastric aspirates from 179 subjects (median 36 weeks, range 31-41 weeks) were eligible for analysis. Spectral analysis of gastric aspirates predicted the need for prolonged respiratory support with 70% sensitivity and 92% specificity. Positive- and negative-predictive values were 86% and 82%, respectively, for the overall cohort. Among gestational age subgroups, positive prediction was highest among moderately preterm neonates (32-33 weeks), while negative prediction was highest among term neonates.
Discussion: Spectral analysis of surfactant components contained in the gastric fluid of neonates ≥30 completed weeks gestation predicts the need for prolonged respiratory support with good performance. Predictive performance varied according to subjects' gestational age at birth, suggesting that gestational age-specific algorithms may improve the performance of this point-of-care diagnostic test.
{"title":"Spectral analysis of gastric aspirates obtained shortly after birth predicts the need for prolonged respiratory support in neonates in a development cohort.","authors":"Brianna C Leigh, Lavonne M Liedl, Amy L Amsbaugh, William A Carey","doi":"10.3389/fped.2025.1686794","DOIUrl":"10.3389/fped.2025.1686794","url":null,"abstract":"<p><strong>Introduction: </strong>Spectral analysis of gastric aspirates obtained shortly after birth predicts the diagnosis of respiratory distress syndrome in neonates born <32 completed weeks gestation. We sought to determine whether this prototype point-of-care device measuring surfactant components in gastric aspirates could predict prolonged respiratory support needs in neonates ≥30 completed weeks gestation.</p><p><strong>Methods: </strong>Gastric aspirates obtained within 30 min of birth were analyzed by spectroscopy to quantify surfactant components. These spectral data were entered into an existing algorithm to assess subjects' biochemical lung maturity. This algorithmic output was paired with clinical data to evaluate the performance of the algorithm in predicting subjects' need for respiratory support at six hours of life (prolonged respiratory support). Each element of the algorithm was adjusted via a machine learning framework to optimize predictive performance.</p><p><strong>Results: </strong>Gastric aspirates from 179 subjects (median 36 weeks, range 31-41 weeks) were eligible for analysis. Spectral analysis of gastric aspirates predicted the need for prolonged respiratory support with 70% sensitivity and 92% specificity. Positive- and negative-predictive values were 86% and 82%, respectively, for the overall cohort. Among gestational age subgroups, positive prediction was highest among moderately preterm neonates (32-33 weeks), while negative prediction was highest among term neonates.</p><p><strong>Discussion: </strong>Spectral analysis of surfactant components contained in the gastric fluid of neonates ≥30 completed weeks gestation predicts the need for prolonged respiratory support with good performance. Predictive performance varied according to subjects' gestational age at birth, suggesting that gestational age-specific algorithms may improve the performance of this point-of-care diagnostic test.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1686794"},"PeriodicalIF":2.0,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12738924/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145849654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Pediatric penile hamartoma is extremely rare. Preoperative imaging often cannot definitively characterize the lesion, and histopathology remains the diagnostic gold standard. We report a child with penile hamartoma and torsion, discuss management, and compare outcomes with the literature.
Methods: We retrospectively analyzed the clinical presentation, imaging, intraoperative findings, and pathology. Relevant reports were reviewed for comparison.
Results: Complete excision of a ventral hamartomatous appendage plus circumcision and release of a fibrous tethering band achieved immediate torsion correction in a single stage. Histopathology showed stratified squamous epithelium with proliferative fibrous and adipose tissue containing nerve bundles, ganglion cells, and focal smooth muscle-consistent with hamartoma. Recovery was uneventful; at 12 months no recurrence was observed.
Conclusion: Etiology-targeted, one-stage correction-degloving (circumcision), release of tethering bands, complete lesion excision, and simultaneous torsion repair-can be safe and effective. Long-term follow-up is advised.
{"title":"Case Report: Penile hamartoma with penile torsion in a child: etiology-targeted one-stage surgical correction and literature review.","authors":"Zhigang Yao, Chenghao Zhanghuang, Nian Zhou, Jinrong Li, Zipeng Hao, Bing Yan, Hui Zhao","doi":"10.3389/fped.2025.1715759","DOIUrl":"10.3389/fped.2025.1715759","url":null,"abstract":"<p><strong>Background: </strong>Pediatric penile hamartoma is extremely rare. Preoperative imaging often cannot definitively characterize the lesion, and histopathology remains the diagnostic gold standard. We report a child with penile hamartoma and torsion, discuss management, and compare outcomes with the literature.</p><p><strong>Methods: </strong>We retrospectively analyzed the clinical presentation, imaging, intraoperative findings, and pathology. Relevant reports were reviewed for comparison.</p><p><strong>Results: </strong>Complete excision of a ventral hamartomatous appendage plus circumcision and release of a fibrous tethering band achieved immediate torsion correction in a single stage. Histopathology showed stratified squamous epithelium with proliferative fibrous and adipose tissue containing nerve bundles, ganglion cells, and focal smooth muscle-consistent with hamartoma. Recovery was uneventful; at 12 months no recurrence was observed.</p><p><strong>Conclusion: </strong>Etiology-targeted, one-stage correction-degloving (circumcision), release of tethering bands, complete lesion excision, and simultaneous torsion repair-can be safe and effective. Long-term follow-up is advised.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1715759"},"PeriodicalIF":2.0,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12738903/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145849231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aim: This study comprehensively analyzed the characteristics and development trends of pediatric interventional drug clinical trials registered between 2015 and 2024, with a focus on pharmaceutical characteristics such as dosage form and administration route.
Methods: The ClinicalTrials.gov database was searched to identify trials involving pediatric participants. Interventional trials first posted between 2015 and 2024 were included if they used drugs as interventions and had treatment as the primary purpose.
Results: A total of 2,928 pediatric-only clinical trials were included, with annual registration numbers ranging from 257 to 339, exhibiting a declining trend. Among these, 1,975 (67.5%) enrolled no more than 100 participants, and 153 (5.2%) were restricted to either males or females, with this gender-specific enrollment correlated with disease epidemiology. Mental, behavioral, or neurodevelopmental disorders (319, 10.9%) represented the most studied therapy area, maintaining high proportions consistently across Phases 1-3. The most common dosage forms were liquid (53.3%) and solid (24.0%), and the most frequently reported administration routes were enteral (39.0%) and parenteral (35.6%). Drug formulations and administration routes varied by age group: the use of solid formulations (from 12.1% to 29.1%) and enteral administration (from 22.9% to 42.0%) increased with age, while the use of liquid formulation and parenteral administration declined.
Conclusion: In the last ten years, registered pediatric drug trials have either stayed stable or slightly decreased, often featuring small sample sizes and rarely using age-specific formulations. National regulatory bodies should boost policy support to encourage pediatric drug research and improve trial design quality.
{"title":"Characteristics of pediatric interventional drug trials registered between 2015 and 2024 on ClinicalTrials.gov.","authors":"Yinghong Zhou, Zhaoxin Liu, Ji Xu, Ying Zhang, Haiqi Shen, Siyu Jiang, Yunyun Shi, Yinghua Lv, Jihan Huang","doi":"10.3389/fped.2025.1695990","DOIUrl":"10.3389/fped.2025.1695990","url":null,"abstract":"<p><strong>Aim: </strong>This study comprehensively analyzed the characteristics and development trends of pediatric interventional drug clinical trials registered between 2015 and 2024, with a focus on pharmaceutical characteristics such as dosage form and administration route.</p><p><strong>Methods: </strong>The ClinicalTrials.gov database was searched to identify trials involving pediatric participants. Interventional trials first posted between 2015 and 2024 were included if they used drugs as interventions and had treatment as the primary purpose.</p><p><strong>Results: </strong>A total of 2,928 pediatric-only clinical trials were included, with annual registration numbers ranging from 257 to 339, exhibiting a declining trend. Among these, 1,975 (67.5%) enrolled no more than 100 participants, and 153 (5.2%) were restricted to either males or females, with this gender-specific enrollment correlated with disease epidemiology. Mental, behavioral, or neurodevelopmental disorders (319, 10.9%) represented the most studied therapy area, maintaining high proportions consistently across Phases 1-3. The most common dosage forms were liquid (53.3%) and solid (24.0%), and the most frequently reported administration routes were enteral (39.0%) and parenteral (35.6%). Drug formulations and administration routes varied by age group: the use of solid formulations (from 12.1% to 29.1%) and enteral administration (from 22.9% to 42.0%) increased with age, while the use of liquid formulation and parenteral administration declined.</p><p><strong>Conclusion: </strong>In the last ten years, registered pediatric drug trials have either stayed stable or slightly decreased, often featuring small sample sizes and rarely using age-specific formulations. National regulatory bodies should boost policy support to encourage pediatric drug research and improve trial design quality.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1695990"},"PeriodicalIF":2.0,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12727638/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145833743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-10eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1720595
Chiara Martis, Annalisa Levante, Flavia Lecciso
This integrative literature review, conducted with a systematic approach, examined how a child's atopic dermatitis affects parental functioning. Fifty-four studies have been reviewed, identifying the key impacts, including work absenteeism, reduced quality of life, increased distress, sleep deprivation, and challenges in parent-child relationships. These dimensions were grouped into three focuses: Parents as workers, individuals, and caregivers. The review found that atopic dermatitis often disrupts parents' careers, causes emotional strain, family burden, and sleep issues. Parent-child interactions may also be affected, potentially impacting the attachment bond. Overall, the findings highlighted the interconnected nature of parental experiences and stressed the need to consider all family members' perspectives. A systemic approach in clinical practice, policy, and research is crucial to better support parents managing their child's condition.
{"title":"When a child lives with atopic dermatitis: an integrative literature review on parental experience.","authors":"Chiara Martis, Annalisa Levante, Flavia Lecciso","doi":"10.3389/fped.2025.1720595","DOIUrl":"10.3389/fped.2025.1720595","url":null,"abstract":"<p><p>This integrative literature review, conducted with a systematic approach, examined how a child's atopic dermatitis affects parental functioning. Fifty-four studies have been reviewed, identifying the key impacts, including work absenteeism, reduced quality of life, increased distress, sleep deprivation, and challenges in parent-child relationships. These dimensions were grouped into three focuses: Parents as workers, individuals, and caregivers. The review found that atopic dermatitis often disrupts parents' careers, causes emotional strain, family burden, and sleep issues. Parent-child interactions may also be affected, potentially impacting the attachment bond. Overall, the findings highlighted the interconnected nature of parental experiences and stressed the need to consider all family members' perspectives. A systemic approach in clinical practice, policy, and research is crucial to better support parents managing their child's condition.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1720595"},"PeriodicalIF":2.0,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12727998/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145833354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-10eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1708452
Sarah Font, Beatriz De Araujo Silva, Dylan Jones
Objective: This study examines the prevalence and predictors of first pregnancy and the use of long-acting reversible contraceptives (LARCs) among adolescent girls aged 12-17 involved in the child welfare system.
Methods: The study leverages linked longitudinal administrative data from the child welfare, juvenile legal, and Medicaid claims systems of Pennsylvania. The sample comprised 28,016 girls born between 2000 and 2005 who received Medicaid and were involved in the child welfare system during adolescence. Survival analysis was used to predict onset of first pregnancy and uptake of LARC.
Results: By age 18, 17% percent of adolescents had experienced pregnant, with 18% having a healthcare encounter to receive LARCs. Foster care placement was not associated with pregnancy but was associated with increased use of LARCs. Substance use disorder, juvenile legal involvement, and recent suspected sexual abuse victimization were positively associated with pregnancy. There was a reciprocal association between LARCs and pregnancy; although any previous encounter for LARCs was negatively associated with pregnancy, uptake of LARCs also increased following a pregnancy.
Conclusions: Despite broad reductions in teen pregnancy over time, adolescent girls with exposure to sexual abuse or engagement in substance use or delinquency face a persistently high risk for very early pregnancy. Medical providers and child welfare agencies need to coordinate service provision to address the sexual and reproductive health needs of at-risk teens.
{"title":"Pregnancy and reproductive healthcare among adolescent girls in the child welfare system.","authors":"Sarah Font, Beatriz De Araujo Silva, Dylan Jones","doi":"10.3389/fped.2025.1708452","DOIUrl":"10.3389/fped.2025.1708452","url":null,"abstract":"<p><strong>Objective: </strong>This study examines the prevalence and predictors of first pregnancy and the use of long-acting reversible contraceptives (LARCs) among adolescent girls aged 12-17 involved in the child welfare system.</p><p><strong>Methods: </strong>The study leverages linked longitudinal administrative data from the child welfare, juvenile legal, and Medicaid claims systems of Pennsylvania. The sample comprised 28,016 girls born between 2000 and 2005 who received Medicaid and were involved in the child welfare system during adolescence. Survival analysis was used to predict onset of first pregnancy and uptake of LARC.</p><p><strong>Results: </strong>By age 18, 17% percent of adolescents had experienced pregnant, with 18% having a healthcare encounter to receive LARCs. Foster care placement was not associated with pregnancy but was associated with increased use of LARCs. Substance use disorder, juvenile legal involvement, and recent suspected sexual abuse victimization were positively associated with pregnancy. There was a reciprocal association between LARCs and pregnancy; although any previous encounter for LARCs was negatively associated with pregnancy, uptake of LARCs also increased following a pregnancy.</p><p><strong>Conclusions: </strong>Despite broad reductions in teen pregnancy over time, adolescent girls with exposure to sexual abuse or engagement in substance use or delinquency face a persistently high risk for very early pregnancy. Medical providers and child welfare agencies need to coordinate service provision to address the sexual and reproductive health needs of at-risk teens.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1708452"},"PeriodicalIF":2.0,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12727893/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145833727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}